معرفی
Dennis Löwik is a Lecturer in Drug Discovery at HAN University of Applied Sciences and holds an associate position at Radboud University Nijmegen. He is also a co-founder and advisor at Aurelius Therapeutics. His research focuses on accelerating early-stage drug discovery through innovative approaches involving natural substances, AI optimization, and advanced drug delivery systems. His mission aims to reduce the time and cost of drug development, currently averaging 12-15 years and €3 billion.
Education:
- MSc in Organic Chemistry (1994) – University of Nijmegen
- PhD in Medicinal Chemistry (1998) – Utrecht University
Research Interests: Dennis specializes in drug discovery processes, smart materials, and targeted drug delivery systems. His work integrates artificial intelligence to optimize drug design and testing, emphasizing collaboration with industry partners through initiatives like the CoE HAN BioCentre. He envisions a future where his research group acts as a hub for Dutch pharmaceutical innovation, solving challenges like designing tick-repellent substances or novel drug compounds.
Professional Milestones:
- Installation as Drug Discovery Lecturer (June 12, 2025) with the inaugural address: "From Molecule to Medicine: From Inspiration to Innovation"
- Extensive career history includes postdoctoral work at Cambridge University, TU Eindhoven, and Radboud University
Collaborations & Impact: Active partnerships with the pharmaceutical sector via the CoE HAN BioCentre and Smart Region initiatives. Focus on translating research into practical solutions through three core areas: natural-source drug development, advanced testing methods, and AI-driven process optimization.
